CAS Medical Systems, Inc. Announces Second Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BRANFORD, Conn., Aug. 7, 2013 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended June 30, 2013. Net sales were $5.0 million for the second quarter of 2013, compared with $5.2 million for the second quarter of 2012. The net loss applicable to common stockholders for the second quarter of 2013 was $2.9 million, or ($0.22) per common share, compared with a net loss applicable to common stockholders of $1.9 million, or ($0.15) per common share, for the second quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
BRANFORD, Conn., Aug. 7, 2013 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended June 30, 2013. Net sales were $5.0 million for the second quarter of 2013, compared with $5.2 million for the second quarter of 2012. The net loss applicable to common stockholders for the second quarter of 2013 was $2.9 million, or ($0.22) per common share, compared with a net loss applicable to common stockholders of $1.9 million, or ($0.15) per common share, for the second quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.